Cargando…
TMEM139 prevents NSCLC metastasis by inhibiting lysosomal degradation of E‐cadherin
Non‐small‐cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases and has the highest mortality rate among all solid tumors. It is characterized by early metastasis, and investigations of the molecular mechanisms underlying the progression and metastasis of NSCLC are urgentl...
Autores principales: | Zhang, Shuai, He, Yunlong, Xuan, Qijia, Ling, Xiaodong, Men, Kaiya, Zhao, Xu, Xue, Dinglong, Li, Ling, Zhang, Yingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207374/ https://www.ncbi.nlm.nih.gov/pubmed/35302694 http://dx.doi.org/10.1111/cas.15341 |
Ejemplares similares
-
Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells
por: Lee, Jee-Hyung, et al.
Publicado: (2023) -
Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018) -
Functional characterization of the lysosomal membrane protein TMEM192 in mice
por: Nguyen, Thuy Linh, et al.
Publicado: (2017) -
Gating and selectivity mechanisms for the lysosomal K(+) channel TMEM175
por: Oh, SeCheol, et al.
Publicado: (2020) -
Mechanism of 4-aminopyridine inhibition of the lysosomal channel TMEM175
por: Oh, SeCheol, et al.
Publicado: (2022)